Creating bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.
July 24, 2023
/PRNewswire/ -- EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The...Read on PRNewswire »
March 9, 2023
EpiBone, emerging biotech company, is relocating to Jersey City — and bringing nearly 100 jobs | ROI-NJ
EpiBone, an emerging biotechnology company co-founded and run by Nina Marie Tandon, is coming to Jersey City after the Board of the New Jersey Economic Development Authority (NJEDA) approved up to...Read on ROI-NJ »
October 17, 2015
EpiBone uses stem cells to regrow damaged bones. After getting a PhD from Columbia, Nina Tandon returned to school for an MBA to form a company at the forefront of 'biology as design.'Read on Inc.com »
More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on EpiBone and over 370 other ventures working to solve the world's toughest problems.